Correlation of CYP2D6 genotype with response to oxycodone in orthopedic injury related pain.

被引：3
|
作者：
Myers, AB [1 ]
Sullivan, JE [1 ]
Koller, DM [1 ]
Godambe, SA [1 ]
Kennedy, MJ [1 ]
机构：
[1] Univ Louisville, Louisville, KY 40292 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.065
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P18 / P18
页数：1
相关论文
共 50 条
  • [1] Correlation of CYP2D6 genotype with response to tetrabenazine
    Mehanna, R.
    Hunter, C.
    Davidson, A.
    Jimenez-Shahed, J.
    Ondo, W.
    Jankovic, J.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S457 - S457
  • [2] IMPACT OF CYP2D6 GENOTYPE ON POSTOPERATIVE INTRAVENOUS OXYCODONE ANALGESIA
    Zwisler, S. T.
    Enggaard, T. P.
    Mikkelsen, S.
    Brosen, K.
    Sindrup, S. H.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 26 - 26
  • [3] CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients
    Stamer, Ulrike M.
    Zhang, Lan
    Book, Malte
    Lehmann, Lutz E.
    Stuber, Frank
    Musshoff, Frank
    [J]. PLOS ONE, 2013, 8 (03):
  • [4] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    [J]. Breast Cancer Research, 7
  • [5] CYP2D6 genotype and tamoxifen response
    Rae, JM
    Goetz, MP
    Hayes, DF
    Ingle, JN
    Li, L
    Storniolo, AM
    Stearns, V
    Flockhart, DA
    [J]. BREAST CANCER RESEARCH, 2005, 7 (05)
  • [6] Analysis of CYP2D6 genotype and response to tetrabenazine
    Mehanna, Raja
    Hunter, Christine
    Davidson, Anthony
    Jimenez-Shahed, Joohi
    Jankovic, Joseph
    [J]. MOVEMENT DISORDERS, 2013, 28 (02) : 210 - 215
  • [7] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    [J]. MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [8] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [9] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    [J]. Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [10] Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
    Susce, Margaret T.
    Murray-Carmichael, Elaina
    de Leon, Jose
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (07): : 1356 - 1358
12345